The Impact of the SCN9A Gene Polymorphism on Postoperative Pain
The Impact of the Single Nucleotide Polymorphisms rs6746030,rs7604448, rs10930214, s7595255 in SCN9A Gene on Postoperative Pain and Analgesic Consumption After Cesarean Section
Sponsor: Tokat Gaziosmanpasa University
Listed as NCT02496455, this observational or N/A phase trial focuses on Pain, Postoperative and Pregnancy and remains completed. Sponsored by Tokat Gaziosmanpasa University, it has been updated 12 times since 2015, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
12 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Dec 2021 — Jul 2024 [monthly]
Completed
-
Jan 2021 — Dec 2021 [monthly]
Completed
▶ Show 7 earlier versions
-
Nov 2020 — Jan 2021 [monthly]
Completed
-
Jun 2018 — Nov 2020 [monthly]
Completed
-
May 2018 — Jun 2018 [monthly]
Completed
-
Apr 2018 — May 2018 [monthly]
Completed
Phase: NA → None
-
Dec 2017 — Apr 2018 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Aug 2017 — Dec 2017 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Jan 2017 — Aug 2017 [monthly]
Recruiting NA
First recorded
Aug 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Tokat Gaziosmanpasa University
For direct contact, visit the study record on ClinicalTrials.gov .